BIO SYSTEMS LABORATORY, LLC
Clinical Medical Laboratory · ARLINGTON, TX
Organization Active NPI 1275364853
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 65 | 361 | $147,602 | $131,499 | $131,499 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 81256 | Gene analysis (hemochromatosis) common variants | 41 | $64 | $64 |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | 32 | $269 | $269 |
| 81333 | Gene analysis (transforming growth factor beta-induced) for common variants | 32 | $134 | $134 |
| 81192 | Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis | 27 | $203 | $203 |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 27 | $182 | $182 |
| 81191 | Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis | 27 | $203 | $203 |
| 81311 | Gene analysis for cancer (neuroblastoma) | 22 | $290 | $290 |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 21 | $629 | $629 |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 21 | $663 | $663 |
| 81185 | Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence | 20 | $829 | $829 |
| 81189 | Gene analysis (cystatin b) of full sequence | 20 | $269 | $269 |
| 81302 | Gene analysis (methyl cpg binding protein 2) full sequence analysis | 20 | $517 | $517 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Clinical Medical Laboratory | 291U00000X | ✓ | — | — |
Other Clinical Medical Laboratory providers in Texas
- NPI 1477143493
- NPI 1205628005
- NPI 1447324025
- NPI 1942013248
- NPI 1225397912
- NPI 1841261344
- NPI 1659302388
- NPI 1134588668
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.